Study of genetic evolution in Mycobacterium tuberculosis isolates from patients with active pulmonary tuberculosis in the Iran and Belarus

Open Microbiology Journal

Volumn 5, Issue , 2011, Pages 32-42

  Bostanabad, Saeed Zaker ^a,b,h   Shekarabei, Mehdi ^b,c   Nojoumi, Seyed Ali ^d   Jabbarzadeh, Esmaeil ^d   Ghalami, Mostafa ^b,e   Kazemi, Vahid Molla ^d   Beigdeli, Mostafa Gholi ^b   Rahimi, Mohammad Karim ^f   Bossak, Mohammad ^f   Sagalchyk, Evgeni Romanovich ^g   Surkova, Larisa Konstantina ^g   Zalutska, Aksana Mikhaelovna ^g   Slizen, Veronika ^h,i   Titov, Leonid Petrovich ^h,i  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b Massoud Laboratory   (Iran)

^c Iran State Medical University   (Iran)

^d PASTEUR INSTITUTE OF IRAN   (Iran)

^e National reference tuberculosis laboratory of Iran   (Iran)

^f ISLAMIC AZAD UNIVERSITY   (Iran)

^g Institute of Pulmonary and Tuberculosis   (Iran)

^h Belarusian Research Institute of Epidemiology and Microbiology   (Iran)

ⁱ Belarusian State Medical University   (Iran)

Author keywords

Iranian and Belarusian isolates; M. tuberculosis; Rate of Genetic Evolution

Indexed keywords

DNA; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; RNA POLYMERASE; RNA POLYMERASE BETA SUBUNIT; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BELARUS; CONTROLLED STUDY; DNA EXTRACTION; EVOLUTIONARY RATE; GENE SEQUENCE; GENETIC CODE; GENOTYPE; IRAN; KATG GENE; LUNG TUBERCULOSIS; MISSENSE MUTATION; MOLECULAR EVOLUTION; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RPOB GENE; SEQUENCE ANALYSIS; STRAIN DIFFERENCE;

MYCOBACTERIUM TUBERCULOSIS;

EID: 79959978541     PISSN: None     EISSN: 18742858     Source Type: Journal    
DOI: 10.2174/1874285801105010032     Document Type: Article

References (24)

1. Abate G, Hoffner SE, Thomsen VO, Miörner H. Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG. Eur J Clin Microbiol Infect Dis 2001; 20:329-333.
2. Bottger E C, Springer B, Pletschette M, Sander P. Fitness of antibiotic-resistant microorganisms and compensatory mutations. Nat Med 1998; 4:1343-4.
3. Davies AP, Billington OJ, Bannister BA, Weir WR, McHugh TD, Gillespie SH. Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment. J Infect 2000; 41:184-7.
4. Davies AP, Billington O J, McHugh T D, Mitchison DA, Gillespie SH. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis. J Clin Microbiol 2000; 38: 3686-3688.
5. Herrera-Leon, Molina L, Saiz T, Saez-Nieto P, Jimenez JA. New Multiplex PCR for Rapid Detection of Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates. Antimicrob Agents Chemother 2005; 49: 144-7.
6. Hughes AL. Contrasting evolutionary rates in the duplicate chaparonin genes of Mycobacterium tuberculosis and M. leprae. Mol Biol Evol 1993; 10:1343-59.
7. Igor EJ, Drobniewski FA, Mangan JA, Butcher PD, Wilson SM. Evaluation of reverse Transcription-PCR and a bacteriophage-Based assey for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis. J Clin Micribiol 1999; 11: 3524-7.
8. Kima JY, Mukherjeea JS, Richa ML, Matea K, Bayonaa J, Becerraa MC. From multi drug resistant tuberculosis to DOTSexpansion and beyond: making the most of a paradigm shift. Tuberculosis 2003; 83: 59-65.
9. Kent PT, Kubica GP. Public health Mycobacteriology, a guide for the level III laboratory, CDC, U.S. Department of health and human service publication no. 1st ed. (CDC) 86-216546. Atlanta, 1985.
10. Kiepiela P, Bishop KS, Smith AN, Roux L, York DF. Chromosomal in the katG, inhA, and ahpC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber Lung Dis 2000; 80:47-56.
11. Kim BJ, Hong SK, Lee KH, et al. Differential Identification of Mycobacterium tuberculosis Complex and Nontuberculous Mycobacteria by Duplex PCR Assay Using the RNA Polymerase Gene (rpoB). J Clin Microbiol 2004; 42: 1308-1312.
12. Leslie H, Kelly AD, Sherri LW, Glenn DR. Evaluation of the microseq system for identification of Mycobacteria by 16S Ribosomal DNA sequencing and Its Integration into a Routine Clinical Mycobacteriology Laboratory. J Clin Micribiol 2003; 2:1447-53.
13. Leung ETY, Kam KM, Chiu AH, Seto PL, Yuen WH, Yam KY. Detection of katG Ser315Thr substitution in respiratory specimens from patients with isoniazid-resistant Mycobacterium tuberculosis using PCR-RFLP. J Med Microbiol 2003; 52: 999-1003.
14. Silva MS, Senna SG, Ribeiro MO, et al. Mutations in katG, inhA, and ahpC Genes of Brazilian Isoniazid-Resistant Isolates Mycobacterium tuberculosis. J Clin Microbiol 2003; 9: 4471-44.
15. Miriam BV, Alfredo PL, Catalina AH, et al. rpoB Gene Mutations in Rifampin-Resistant Mycobacterium tuberculosis Identified by Polymerase Chain Reaction Single- Stranded Conformational Polymorphism. Emerging Infection Disease 2001; 7: 1010-3.
16. Mekonnen K, Øivind E, Sandaae RA, Eshetu LB. Amplified ribosomal DNA restriction analysis in the differentiation of related species of mycobacteria. J Microbiol Methods 2003; 55-83.
17. Garcia M, Vargas JA, Castejon R, Navasw E, Durantez A. Flowcytometric assessment of lymphocyte cytokine production in tuberculosis. Tuberculosis 2002; 82: 37 - 41
18. Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L and Vyshnevskiy B. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother 2002; 46: 1417- 24.
19. Sajduda A, Anna A, Popławska M, et al. Molecular Characterization of Rifmpicine- and Isoniazid-Resistant Mycobacterium tuberculosis Strains Isolated in Poland. J Clin Microbiol 2004; 42:2425-31.
20. Telenti A, Honore N, Brenasconi C, March J, Ortega HT, Cole ST. Genotyping assessment of isoniazid and rifmpicine resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 1997; 35:719-23.
21. Telenti A, Imboden P, Marchesi F, et al. Detection of rifampicinresistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341:647-50.
22. Titov LP, Zaker SB, Slizen V, Surkova L, Taghikhani M, Bahrmand A. Molecular characterization of rpoB gene mutations in rifampicin- resistant Mycobacterium tuberculosis isolates from tuberculosis patients in Belarus. Biotechnol J 2006; 24:1447-52.
23. Zaker SB, Titov LP, Bahrmand AR, Taghikhani M. Genetic mechanicm of mycobacterium tuberculosis resistance to antituberculsis drugs, isoniaszid and rifampicine. J Dakladi Hational Akademia Sci Belarus 2006; 50: 92-8.
24. Zaker BS, Seyed AN, Mohammad KK, et al. Characterization of molecular evolution in multi-drug resistant Mycobacterium tuberculosis in patients with active pulmonary tuberculosis of different regions in Belarus 2009; 1: 39-49.